Why Sudden Cardiac Arrest Kills 250,000 Russians Annually—and How to Spot the Warning Signs
Why Sudden Cardiac Arrest Kills 250,000 Russians Annually—and How to Spot the Warning Signs
Why Sudden Cardiac Arrest Kills 250,000 Russians Annually—and How to Spot the Warning Signs
Sudden cardiac arrest remains a major health threat in Russia, claiming up to 250,000 lives each year. The condition can strike without warning, even in young and seemingly healthy people. Survival rates stay low, rarely exceeding 20%, even when medical help arrives quickly.
Warning signs of sudden cardiac arrest include fainting, seizures, a rapid pulse, nausea, high fever, and irregularities on an ECG. Conditions like ischemic heart disease, heart failure, and ventricular tachycardia also raise the risk of sudden death. Mental health struggles and certain psychotropic drugs can further disrupt heart rhythms.
Ignoring these symptoms can have deadly consequences. Experts urge regular medical check-ups, even for those without obvious heart health issues. Heart disease is already Russia's leading cause of death, accounting for 56.7% of all fatalities. Yet specific data on sudden cardiac deaths in people under 36 remains unavailable.
Sudden cardiac arrest continues to pose a serious risk, particularly when early warning signs go unnoticed. While overall heart disease statistics are clear, more detailed research is needed to understand age-specific patterns. Preventive measures and prompt medical attention remain critical to reducing deaths.
Garlic, Vitamin C, and Chlorophyll Team Up for Heart Health Breakthrough
Could a simple blend of garlic, vitamin C, and chlorophyll be the key to a healthier heart? New findings reveal surprising benefits for blood pressure and beyond.
Chuck Norris, 86, hospitalized after medical emergency in Hawaii
From Walker, Texas Ranger to recent films, Norris never slowed down—until now. Fans worldwide await news after his sudden hospitalization.
Blood Test Breakthrough Could Detect Hidden Artery Disease Years Earlier
A simple blood test could soon reveal invisible plaque buildup—long before it triggers a deadly event. Machine learning cracked the code in 45,000 patients' data.
Eli Lilly's retatrutide shows groundbreaking results in Type 2 diabetes trial
A triple-hormone drug could redefine diabetes care. Early data shows retatrutide outperforms competitors—but will regulators agree?